TG Therapeutics and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI® (ublituximab-xiiy)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. USO
2. NVDA
3. META
4. SPY
5. DCOY
6. MSFT
7. VKTX
8. PRGS
9. WOR
10. LGND

Go back to TG Therapeutics and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI® (ublituximab-xiiy)
TG THERAP (NASDAQ: TGTX) Delayed: 58.11 +0.95 (1.66%)
Previous Close $57.16    52 Week High $14.87 
Open $57.41    52 Week Low $4.90 
Day High $58.62    P/E N/A 
Day Low $56.56    EPS $-0.67 
Volume 2,084,617